# Advances in protein dot blot: principles, technical specifics, applications, and future perspectives

**Authors:** Juan Lu, Feng-yi Mai, Xin-yu Li, Wen-tao Yang, Jing-rong Liang, Xing-long Li, Jie Guo, Chen-guang Li

PMC · DOI: 10.3389/fmolb.2026.1768231 · Frontiers in Molecular Biosciences · 2026-01-23

## TL;DR

Protein dot blot is a fast and cost-effective method for protein analysis that skips electrophoresis, but has limitations like low sensitivity and non-specific binding.

## Contribution

This review provides a comprehensive overview of protein dot blot's principles, technical factors, and recent innovations to guide future improvements.

## Key findings

- Protein dot blot offers simplicity and high throughput for protein analysis.
- Recent applications include clinical biomarker detection and food safety testing.
- Future improvements may involve nanomaterials and microfluidics integration.

## Abstract

Protein dot blot is an efficient immunoblotting technique enabling qualitative/semi-quantitative protein analysis without electrophoresis, relying on antigen-antibody binding. Its workflow involves direct sample spotting on membranes, blocking, antibody incubation, and signal detection, completing within 3–5 h. Advantages include simplicity, high throughput, micro-sample compatibility, and cost-effectiveness, supporting basic life science research and clinical testing. However, it faces limitations like narrow dynamic range, inability to resolve protein variants, susceptibility to non-specific binding, and sensitivity to operational variables. This review systematically elaborates on its principles and procedures, analyzes key factors influencing sensitivity, and repeatability, and focuses on recent application progress in protein analysis, clinical biomarker detection, and food safety, along with technical innovations. It aims to provide comprehensive references for researchers and a theoretical basis for further optimization, with future advancements likely involving nanomaterial-based signal amplification, engineered antibodies, and integration with microfluidics or mass spectrometry to expand utility in biomedicine and public health.

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12877402/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12877402/full.md

## References

66 references — full list in the complete paper: https://tomesphere.com/paper/PMC12877402/full.md

---
Source: https://tomesphere.com/paper/PMC12877402